Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 9

1.

The HLA-DRA variation rs3129882 is not associated with Parkinson's disease in Sweden.

Ran C, Willows T, Sydow O, Johansson A, Söderkvist P, Dizdar N, Ahmadi A, Olson L, Belin AC.

Parkinsonism Relat Disord. 2013 Jul;19(7):701-2. doi: 10.1016/j.parkreldis.2013.03.001. Epub 2013 Apr 8. No abstract available.

PMID:
23579001
[PubMed - indexed for MEDLINE]
Free Article
2.

CMV-associated encephalitis and antineuronal autoantibodies--a case report.

Xu X, Bergman P, Willows T, Tammik C, Sund M, Hökfelt T, Söderberg-Naucler C, Varani S.

BMC Neurol. 2012 Sep 4;12:87. doi: 10.1186/1471-2377-12-87.

PMID:
22947340
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Association of a protective paraoxonase 1 (PON1) polymorphism in Parkinson's disease.

Belin AC, Ran C, Anvret A, Paddock S, Westerlund M, Håkansson A, Nissbrandt H, Söderkvist P, Dizdar N, Ahmadi A, Anvret M, Willows T, Sydow O, Galter D.

Neurosci Lett. 2012 Jul 26;522(1):30-5. doi: 10.1016/j.neulet.2012.06.007. Epub 2012 Jun 13.

PMID:
22704918
[PubMed - indexed for MEDLINE]
4.

Genetic Screening of the Mitochondrial Rho GTPases MIRO1 and MIRO2 in Parkinson's Disease.

Anvret A, Ran C, Westerlund M, Sydow O, Willows T, Olson L, Galter D, Belin AC.

Open Neurol J. 2012;6:1-5. doi: 10.2174/1874205X01206010001. Epub 2012 Apr 3.

PMID:
22496713
[PubMed]
Free PMC Article
5.

Genetic studies of the protein kinase AKT1 in Parkinson's disease.

Ran C, Westerlund M, Anvret A, Willows T, Sydow O, Galter D, Belin AC.

Neurosci Lett. 2011 Aug 21;501(1):41-4. doi: 10.1016/j.neulet.2011.06.038. Epub 2011 Jun 29.

PMID:
21741444
[PubMed - indexed for MEDLINE]
6.

DJ-1 Mutations are Rare in a Swedish Parkinson Cohort.

Anvret A, Blackinton JG, Westerlund M, Ran C, Sydow O, Willows T, Håkansson A, Nissbrandt H, Belin AC.

Open Neurol J. 2011 Mar 22;5:8-11. doi: 10.2174/1874205X01105010008.

PMID:
21532868
[PubMed]
Free PMC Article
7.

A pharmacokinetic-pharmacodynamic model for duodenal levodopa infusion.

Westin J, Nyholm D, Pålhagen S, Willows T, Groth T, Dougherty M, Karlsson MO.

Clin Neuropharmacol. 2011 Mar-Apr;34(2):61-5. doi: 10.1097/WNF.0b013e31820b570a.

PMID:
21297456
[PubMed - indexed for MEDLINE]
8.

Variations of the CAG trinucleotide repeat in DNA polymerase γ (POLG1) is associated with Parkinson's disease in Sweden.

Anvret A, Westerlund M, Sydow O, Willows T, Lind C, Galter D, Belin AC.

Neurosci Lett. 2010 Nov 19;485(2):117-20. doi: 10.1016/j.neulet.2010.08.082. Epub 2010 Sep 6.

PMID:
20826197
[PubMed - indexed for MEDLINE]
9.

Long-term 24-hour duodenal infusion of levodopa: outcome and dose requirements.

Nyholm D, Jansson R, Willows T, Remahl IN.

Neurology. 2005 Nov 8;65(9):1506-7. No abstract available.

PMID:
16275852
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk